Is ENGASE p.Val169Ile (c.505G>A) pathogenic?

ENGASE p.Val169Ile (c.505G>A) is classified Benign in ENGASE (ClinVar, Single submitter, 1 submitter; last evaluated 2018-01-08). AlphaMissense: likely benign (0.0921); Low-frequency (popmax 2.4%, afr).

How common is ENGASE p.Val169Ile (c.505G>A) in the general population?

ENGASE p.Val169Ile (c.505G>A) is low-frequency (popmax 2.4%, afr) (gnomAD).

What do computational predictors say about ENGASE p.Val169Ile (c.505G>A)?

AlphaMissense predicts likely benign (score 0.0921) — an in-silico prediction, not a clinical call.

ENGASE p.Val169Ile

c.505G>A · rs36073943 · VCV788611

Benign Single submitter

Classification

Benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0921 · ACMG-weighted

gnomAD v4.1

Rare

low-frequency (popmax 2.4%, afr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0921	likely benign
REVEL	0.111	moderately benign-leaning
SaProt	LLR -8.69	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 8.2	GERP 0.78, phastCons 1
Regional constraint	o/e 0.95	unconstrained · MANE · 11 kb · p 0.15 · regional, not allelic
Overall
CADD	23.8	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 2.4% African / African-American · 1,803/75,004 alleles

Filtering AF 2.31% ClinGen BA1/BS1 input FAF95, joint · FAF99 2.27%

Overall 0.124% 2,007/1,614,016 alleles · low-frequency

Ancestry group	Frequency	1 in
African / African-Americangrpmax	2.4%	42
Admixed American	0.135%	741
Remaining individualsnot grpmax-eligible	0.122%	822
Middle Eastern	0.099%	1,010
South Asian	0.00439%	22,768
European (non-Finnish)	0.00314%	31,892

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: ENGASE
Protein: p.Val169Ile
Coding: c.505G>A
MANE Select: NM_001042573
dbSNP: rs36073943
Type: single nucleotide variant
Location: chr17:79079577 (GRCh38)
Gene constraint: LOEUF 1.018 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 86.41

Full ENGASE gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

ENGASE p.Arg555His Benign ★★ same type
ENGASE c.873-1G>A Uncertain significance ★ same type
ENGASE p.Ala107Val Uncertain significance ★ ⚠ same type
ENGASE p.Ala217Asp Uncertain significance ★ ⚠ same type
ENGASE p.Ala244Val Uncertain significance ★ ⚠ same type
ENGASE p.Ala24Gly Uncertain significance ★ ⚠ same type
ENGASE p.Ala420Val Uncertain significance ★ ⚠ same type
ENGASE p.Ala692Thr Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/engase-p-val169ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown